Research Article

A Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family

Table 1

Laboratory investigations of the WAS patient.

Test itemsResult (normal)

Platelets ()13 ↓ (125~350)
Mean platelet volume (fL)6.60 ↓ (9.20~12.00)
Width of platelet volume distribution (fL)16.00 ↑ (9.60~12.00)
Thrombocytocrit (%)0.01 ↓ (0.19~0.39)
Red blood cells ()5.18 (4.30~5.80)
Hemoglobin (g/L)156.0(130.0 ~ 175.0)
White blood cell numbers ()11.10 ↑ (3.50~9.50)
Neutrophil numbers ()6.88 ↑ (1.80~6.30)
Neutrophil percentage (%)61.73 (40.00~75.00)
Mononuclear cell numbers ()0.86 ↑ (0.10~0.60)
Mononuclear cell percentage (%)7.68 (3.00~10.00)
Lymphocyte numbers ()3.25 ↑ (1.10~3.20)
Lymphocyte percentage (%)29.14 (20.00~50.00)
CD3+ (%)65.50 (60.00~80.00)
Th () (%)36.90 (30.09~40.41)
Ts () (%)23.80 (20.74~29.42)
Th/Ts (%)1.55 (0.98~1.94)
(%)30.50 ↑ (8.10~25.60)
(%)0.40 (≤5.00)
CD19+ (%)7.90 ↓ (9.00~15.00)
IgA (g/L)4.07 (0.82~4.53)
IgG (g/L)7.97 (7.51~15.60)
IgM (g/L)0.20 ↓ (0.46~3.04)
Control (%)0.40 (0-3.00)
PlaIgA (%)1.50 (0-10.0)
PlaIgG (%)2.60 (0-10.0)
PlaIgM (%)1.30 (0-10.0)